Cartesian Therapeutics (RNAC) Other financing activities (2015 - 2026)
Cartesian Therapeutics (RNAC) posted quarterly Other financing activities of $279000.0 for Q1 2026, up 52.46% year-over-year from $183000.0 in Q1 2025, and up 204.1% quarter-over-quarter from -$268000.0 in Q3 2025.
Powered by 
Analysis
Cartesian Therapeutics (RNAC) Other financing activities (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has reported Other financing activities for 10 consecutive years, with $279000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other financing activities rose 52.46% year-over-year to $279000.0; the TTM figure through Mar 2026 stood at $96000.0 (down 99.92% YoY), while the FY2024 annual figure was $124.4 million, changed N/A from the prior year.
- Other financing activities advanced to $279000.0 in Q1 2026 per RNAC's latest filing, from -$268000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $121.6 million in Q3 2024 and bottomed at -$268000.0 in Q3 2025.
- Historically, Other financing activities has averaged $12.5 million across 4 years, with a median of $95500.0 in 2022.
- Annual changes were most pronounced in 2022 — Other financing activities surged 91.03% — and 2025, when it sank 100.22%.
- Cartesian Therapeutics' Other financing activities stood at -$46000.0 in 2022, then jumped by 264363.04% to $121.6 million in 2024, then tumbled by 100.22% to -$268000.0 in 2025, then surged by 204.1% to $279000.0 in 2026.
- Business Quant data shows RNAC's Other financing activities at $279000.0 in Q1 2026, -$268000.0 in Q3 2025, and $85000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Cartesian Therapeutics | 271.98 Mn | 271.98 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 398,000.00 |
| Mar 31, 2026 | 279,000.00 |
| Dec 31, 2025 | 50,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 85,000.00 |
| Mar 31, 2025 | 183,000.00 |
| Sep 30, 2024 | 121.56 Mn |
| Mar 31, 2024 | 2.88 Mn |
| Sep 30, 2023 | 82,000.00 |
| Mar 31, 2023 | 149,000.00 |
| Dec 31, 2022 | -36.67 Mn |
| Sep 30, 2022 | -31,000.00 |
| Jun 30, 2022 | 36.76 Mn |
| Mar 31, 2022 | 127,000.00 |
| Dec 31, 2021 | 104,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Jun 30, 2021 | 428,000.00 |
| Mar 31, 2021 | 244,000.00 |
| Dec 31, 2020 | -1,000.00 |
| Sep 30, 2020 | 5.89 Mn |